Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q3874700> ?p ?o }
Showing triples 1 to 34 of
34
with 100 triples per page.
- Q3874700 subject Q6900265.
- Q3874700 subject Q7139608.
- Q3874700 subject Q7145140.
- Q3874700 subject Q8705202.
- Q3874700 subject Q8824845.
- Q3874700 subject Q9067026.
- Q3874700 abstract "Neosalvarsan is a synthetic chemotherapeutic that is an organoarsenic compound. It became available in 1912 and superseded the more toxic and less water-soluble salvarsan as an effective treatment for syphilis. Because both of these arsenicals carried considerable risk of side effects, they were replaced for this indication by penicillin in the 1940s. Both salvarsan and neosalvarsan were developed in the laboratory of Paul Ehrlich in Frankfurt, Germany. Their discoveries were the result of the first organized team effort to optimize the biological activity of a lead compound through systematic chemical modifications. This scheme is the basis for most modern pharmaceutical research. Both salvarsan and neosalvarsan are prodrugs — that is, they are metabolised into the active drug in the body.".
- Q3874700 thumbnail Neosalvarsan.svg?width=300.
- Q3874700 wikiPageWikiLink Q1057.
- Q3874700 wikiPageWikiLink Q12140.
- Q3874700 wikiPageWikiLink Q12190.
- Q3874700 wikiPageWikiLink Q1794.
- Q3874700 wikiPageWikiLink Q183.
- Q3874700 wikiPageWikiLink Q2477421.
- Q3874700 wikiPageWikiLink Q410762.
- Q3874700 wikiPageWikiLink Q41083.
- Q3874700 wikiPageWikiLink Q57089.
- Q3874700 wikiPageWikiLink Q603741.
- Q3874700 wikiPageWikiLink Q6900265.
- Q3874700 wikiPageWikiLink Q7139608.
- Q3874700 wikiPageWikiLink Q7145140.
- Q3874700 wikiPageWikiLink Q8705202.
- Q3874700 wikiPageWikiLink Q8824845.
- Q3874700 wikiPageWikiLink Q903238.
- Q3874700 wikiPageWikiLink Q9067026.
- Q3874700 wikiPageWikiLink Q974135.
- Q3874700 type ChemicalCompound.
- Q3874700 type ChemicalSubstance.
- Q3874700 type ChemicalObject.
- Q3874700 type Thing.
- Q3874700 type Q11173.
- Q3874700 comment "Neosalvarsan is a synthetic chemotherapeutic that is an organoarsenic compound. It became available in 1912 and superseded the more toxic and less water-soluble salvarsan as an effective treatment for syphilis. Because both of these arsenicals carried considerable risk of side effects, they were replaced for this indication by penicillin in the 1940s. Both salvarsan and neosalvarsan were developed in the laboratory of Paul Ehrlich in Frankfurt, Germany.".
- Q3874700 label "Neosalvarsan".
- Q3874700 depiction Neosalvarsan.svg.